Kisspharma's subsidiary to sell finished products instead of recycled battery materials... "entering ESS business"
Predicted impact: Low· Actual: −17.5% vs sector, volume 0.8× normal (5 trading days)
Subsidiary business shift into ESS; no size or revenue figures given.